393 related articles for article (PubMed ID: 21875872)
1. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
2. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
4. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
6. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
8. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types.
Chiang EY; Yu X; Grogan JL
J Immunol; 2011 Jan; 186(2):1279-88. PubMed ID: 21160042
[TBL] [Abstract][Full Text] [Related]
9. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
11. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
12. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of TLR7 and TLR9 in murine SLE.
Santiago-Raber ML; Baudino L; Izui S
J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
[TBL] [Abstract][Full Text] [Related]
14. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
15. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
16. Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
Gong L; Wang Y; Zhou L; Bai X; Wu S; Zhu F; Zhu YF
Am J Nephrol; 2014; 40(4):325-44. PubMed ID: 25341693
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
18. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
Lye E; Dhanji S; Calzascia T; Elford AR; Ohashi PS
Eur J Immunol; 2008 Mar; 38(3):870-6. PubMed ID: 18286567
[TBL] [Abstract][Full Text] [Related]
19. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling.
Lech M; Lorenz G; Kulkarni OP; Grosser MO; Stigrot N; Darisipudi MN; Günthner R; Wintergerst MW; Anz D; Susanti HE; Anders HJ
Ann Rheum Dis; 2015 Dec; 74(12):2224-35. PubMed ID: 25135254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
